10.47

3.68% -0.40

Rocket Pharmaceuticals Inc (RCKT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$10.87

Offen:

$10.99

24-Stunden-Volumen:

1.07M

Relative Volume:

0.76

Marktkapitalisierung:

$1.11B

Einnahmen:

Nettoeinkommen (Verlust:

$-258.08M

KGV:

-3.8073

EPS:

-2.75

Netto-Cashflow:

$-202.32M

1W Leistung:

+0.00%

1M Leistung:

+3.05%

6M Leistung:

-47.65%

1J Leistung:

-63.31%

1-Tages-Spanne:

$10.42

$11.08

1-Wochen-Bereich:

$10.42

$11.11

52-Wochen-Spanne:

$9.33

$31.47

Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile

Firmenname

Rocket Pharmaceuticals Inc

Sektor

Healthcare (1169)

Branche

Biotechnology (678)

Telefon

646-440-9100

Adresse

350 FIFTH AVENUE, NEW YORK, NY

Mitarbeiter

268

Twitter

@rocketpharma

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

RCKT's Discussions on Twitter

Vergleichen Sie RCKT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RCKT Rocket Pharmaceuticals Inc	10.47	1.11B	0	-258.08M	-202.32M	-2.75
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-30	Eingeleitet	Wedbush	Outperform
2024-12-18	Eingeleitet	Jefferies	Buy
2024-10-16	Eingeleitet	Scotiabank	Sector Outperform
2024-04-02	Eingeleitet	Goldman	Neutral
2023-10-24	Eingeleitet	Cantor Fitzgerald	Overweight
2023-02-01	Eingeleitet	Morgan Stanley	Overweight
2022-11-08	Eingeleitet	Canaccord Genuity	Buy
2022-11-01	Eingeleitet	BTIG Research	Buy
2022-07-08	Eingeleitet	Raymond James	Outperform
2021-10-20	Fortgesetzt	Cowen	Outperform
2021-03-02	Eingeleitet	Stifel	Buy
2021-02-18	Eingeleitet	Needham	Buy
2020-12-16	Eingeleitet	UBS	Buy
2020-12-08	Herabstufung	Oppenheimer	Outperform → Perform
2020-07-02	Eingeleitet	JP Morgan	Overweight
2020-06-25	Fortgesetzt	BofA/Merrill	Buy
2020-06-01	Fortgesetzt	Oppenheimer	Outperform
2019-11-06	Eingeleitet	Chardan Capital Markets	Buy
2019-09-26	Eingeleitet	Piper Jaffray	Overweight
2019-04-23	Eingeleitet	Robert W. Baird	Outperform
2019-03-15	Eingeleitet	BofA/Merrill	Buy
2019-02-05	Eingeleitet	Oppenheimer	Outperform
2018-09-13	Eingeleitet	Ladenburg Thalmann	Buy
2018-07-10	Eingeleitet	William Blair	Outperform

Alle ansehen

Rocket Pharmaceuticals Inc Aktie (RCKT) Neueste Nachrichten

05:03 AM

Rocket Pharmaceuticals (RCKT) Projected to Post Quarterly Earnings on Monday - Defense World

05:03 AM

Feb 19, 2025

Long Term Trading Analysis for (RCKT) - Stock Traders Daily

Feb 19, 2025

Feb 17, 2025

2 Soaring Stocks to Hold for the Next 20 Years - The Globe and Mail

Feb 17, 2025

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Feb 17, 2025

Feb 14, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Hits New 52-Week LowHere's Why - MarketBeat

Feb 14, 2025

Sovran Advisors LLC Acquires New Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat

Feb 14, 2025

RCKT stock touches 52-week low at $9.76 amid market challenges - MSN

Feb 14, 2025

Feb 13, 2025

Strategic Financial Concepts LLC Takes Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Feb 13, 2025

Feb 12, 2025

Rocket Pharma Is A Buy At These Prices With Promising Data (NASDAQ:RCKT) - Seeking Alpha

Feb 12, 2025

Feb 10, 2025

Jennison Associates LLC Purchases 29,564 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat

Feb 10, 2025

It makes sense and dollars to buy Rocket Pharmaceuticals Inc (RCKT) stock - SETE News

Feb 10, 2025

Feb 08, 2025

(RCKT) Long Term Investment Analysis - Stock Traders Daily

Feb 08, 2025

Feb 07, 2025